United Kingdom · Series F startup
Funding summaryUpdated 26 Oct 2026
$133Mraised across 4 rounds since 2003, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by xconomy.comSEC filing: $19M sold, first sale Nov 2009
Omnes
Scottish Equity Partners
Forbion Capital Partners
Crédit Agricole
New Science Venture
Triathlon Medical Venture PartnersReported by fiercebiotech.comSEC filing: $19M sold, first sale Mar 2009
SVB CapitalScottish Equity Partners
Oxford Finance LLC
ABN AMRO FundNew Science VentureTriathlon Medical Venture Partners
Credit Agricole CIBFrom a historical funding record
Temasek HoldingsScottish Equity PartnersABN AMRO Fund
LDCReported by thefreelibrary.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
BioVex's investors include Scottish Equity Partners, Avalon Ventures, Harris & Harris Group, ABN AMRO Fund and New Science Venture, and 21 more on record.
BioVex has raised $133M across 4 rounds since 2003.
BioVex's most recent round was a Series F of $30M in Nov 2009.
BioVex's largest round on record is $40M (Series F), in Mar 2009.
BioVex's first round on record, in Oct 2003, was backed by Temasek Holdings, Scottish Equity Partners and Avalon Ventures and 8 others.
BioVex's latest named round is a Series F, in Nov 2009.
BioVex is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
